S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

Go back to S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.41 +0.05 (0.14%)
Previous Close $36.36    52 Week High $66.55 
Open $35.89    52 Week Low $37.82 
Day High $36.56    P/E N/A 
Day Low $35.42    EPS $0.00 
Volume 1,918,832